Oxford Asset Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,410
Closed -$89.1K 622
2024
Q4
$89.1K Buy
+27,410
New +$98.7K 0.04% 401
2020
Q1
Sell
-142,481
Closed -$1.55M 839
2019
Q4
$1.55M Buy
142,481
+88,515
+164% +$876K 0.04% 581
2019
Q3
$689K Buy
53,966
+43,676
+424% +$629K 0.02% 1124
2019
Q2
$175K Buy
+10,290
New +$177K ﹤0.01% 1571
2019
Q1
Sell
-161,486
Closed -$2.05M 1849
2018
Q4
$2.05M Buy
161,486
+71,906
+80% +$1.21M 0.05% 453
2018
Q3
$1.92M Buy
89,580
+43,633
+95% +$930K 0.04% 687
2018
Q2
$961K Sell
45,947
-83,768
-65% -$1.89M 0.02% 1060
2018
Q1
$3.26M Buy
+129,715
New +$3.15M 0.07% 325
2017
Q2
Sell
-17,637
Closed -$328K 1607
2017
Q1
$328K Sell
17,637
-25,493
-59% -$492K 0.01% 1172
2016
Q4
$882K Sell
43,130
-33,158
-43% -$835K 0.03% 496
2016
Q3
$2.28M Sell
76,288
-20,129
-21% -$599K 0.07% 378
2016
Q2
$2.6M Buy
96,417
+42,898
+80% +$967K 0.09% 320
2016
Q1
$1M Sell
53,519
-102,785
-66% -$1.96M 0.03% 504
2015
Q4
$4.86M Buy
+156,304
New +$4.75M 0.11% 189

Other funds holding MGNX

Oxford Asset Management's MGNX Position: Q1 2025 in Review

Oxford Asset Management sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 27,410 shares — an estimated $89.1K sold.

Oxford Asset Management first reported a position in MGNX in Q4 2015 and held it in 14 quarters. The position peaked at $4.86M in Q4 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • Oxford Asset Management reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • Oxford Asset Management sold 27,410 MacroGenics shares in Q1 2025, an estimated $89.1K.
  • Oxford Asset Management first reported a position in MacroGenics in Q4 2015 and held it in 14 quarters.
  • Oxford Asset Management's MacroGenics position peaked at $4.86M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.